Imaging glucose metabolism to reveal tumor progression
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Purpose: To analyze and review the progress of glucose metabolism-based molecular imaging in detecting tumors to guide clinicians for new management strategies. Summary: When metabolic abnormalities occur, termed the Warburg effect, it simultaneously enables excessive cell proliferation and inhibits cell apoptosis. Molecular imaging technology combines molecular biology and cell probe technology to visualize, characterize, and quantify processes at cellular and subcellular levels in vivo. Modern instruments, including molecular biochemistry, data processing, nanotechnology, and image processing, use molecular probes to perform real-time, non-invasive imaging of molecular and cellular events in living organisms. Conclusion: Molecular imaging is a non-invasive method for live detection, dynamic observation, and quantitative assessment of tumor glucose metabolism. It enables in-depth examination of the connection between the tumor microenvironment and tumor growth, providing a reliable assessment technique for scientific and clinical research. This new technique will facilitate the translation of fundamental research into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIGURE 2 Overview of glycolysis routes detectable with various imaging techniques. PET with 18F-FDG may detect glucose uptake; MRS with 13C-Glucose can be used for optical imaging. Pyruvate kinase M2 (PKM2) is detectable with PET utilizing [18F]DASA-23, [18F]FDG, and [11C]DASA-23. Contribution of pyruvate and lactate may be assessed using 13C-Pyruvate and 13C-Lactate utilizing MRS. Combining imaging modalities with quantitative immunohistochemistry allows the assessment of total protein levels and phosphorylation.](https://figures.cochat.ai/paper-figures/08d2895181234e67851c730d9cf114aa/imaging-glucose-metabolism-to-reveal-tumor-progression-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other imaging modalities based on increased glucose uptake such as using [1–13C] glucose or [6,6-2H2]glucose magnetic resonance spectroscopy, or using tracers based on other indicators of glycolysis such as increased lactate production have also been utilized or are currently under development [53, 54].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846 · cited 1×
“In addition, a unique software algorithm, “Glyoxia,” has been developed (Bi et al., 2019; Moscoso et al., 2019), which can detect glycolysis and hypoxia through the automatic processing of 18F-FDG and 18F-FMISO PET images.”
MethodFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 1×
“Therefore, after the injection of HP [1-13C] pyruvate, rapid 13C MR was used to measure the metabolic conversion of this aggressive cancer and its response to treatment, with direct biological significance (Fantin et al., 2006; Keshari et al., 2013a; Keshari et al., 2013b; Wilson and Kurhanewicz, 2014).”
MethodThe cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
Metabolic regulation of cell growth and proliferation
Zhu, J., & Thompson, C. B. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0123-5 · Cited by 1,116
Science Translational Medicine
(2013) · Science Translational Medicine · doi:10.1126/scitranslmed · Cited by 859
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Kraehenbuehl, L., Weng, C.-H., Eghbali, S., Wolchok, J. D., & Merghoub, T. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00552-7 · Cited by 846
Spatial omics and multiplexed imaging to explore cancer biology
Lewis, S. M., Asselin-Labat, M.-L., Nguyen, Q., Berthelet, J., Tan, X., Wimmer, V. C., Merino, D., Rogers, K. L., & Naik, S. H. (2021) · Nature Methods · doi:10.1038/s41592-021-01203-6 · Cited by 619
Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα
Guo, D., Tong, Y., Jiang, X., Meng, Y., Jiang, H., Du, L., Wu, Q., Li, S., Luo, S., Li, M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.002 · Cited by 423
Self-citationMicroRNA-mediated regulation of glucose and lipid metabolism
Agbu, P., & Carthew, R. W. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00354-w · Cited by 363
Molecular imaging in oncology: Current impact and future directions
Rowe, S. P., & Pomper, M. G. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21713 · Cited by 337
Cited by
Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
Aden, D., Sureka, N., Zaheer, S., Chaurasia, J. K., & Zaheer, S. (2024) · Immunology · doi:10.1111/imm.13871 · Cited by 66
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Uncovering Porphyrin Accumulation in the Tumor Microenvironment
Adapa, S. R., Sami, A., Meshram, P. U., Ferreira, G. C., & Jiang, R. H. Y. (2024) · Genes · doi:10.3390/genes15070961 · Cited by 11
Ren, L.-K., Lu, R., Fei, X., Chen, S., Liu, P., Zhu, C., Wang, X., & Pan, Y. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05644-2 · Cited by 8
Addissouky, T. A. (2026) · Journal of Rare Diseases · doi:10.1007/s44162-026-00147-9 · Cited by 6
Metadata
- Authors
- Meng, Y., Sun, J., Zhang, G., Yu, T., & Piao, H.
- Affiliations
- Liaoning Cancer Hospital & Institute (CN)
- Corresponding author
- Yu, Tao
- Piao, Haozhe
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-02
- Volume
- 14
- Pages
- 1103354-1103354
- ISSN
- 1664-042X (ISSN-L)
- PMC
- PMC9932271
- OpenAlex
- W4319036440
- Cited by
- 10
- References
- 115
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Physiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundamental Research Funds for the Central Universities
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
- Keywords
- glucose metabolism, tumor progression, molecular imaging, Warburg effect, tumor microenvironment, non-invasive cancer detection, molecular probes, cell proliferation, apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imaging glucose metabolism to reveal tumor progression. https://app.cochat.ai/papers/10.3389/fphys.2023.1103354
- The paper
- Meng, Y., Sun, J., Zhang, G., Yu, T., & Piao, H. (2023). Imaging glucose metabolism to reveal tumor progression. Frontiers in Physiology. https://doi.org/10.3389/fphys.2023.1103354
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.